Panacea Biotec Share Price

Panacea Biotec (INR)335.5-14.3   (-4.1%)

Exchange ScripsBSE531349NSEPANACEABIOISININE922B01023

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Panacea Biotec Performance

Market performance
Open price353.85
High363
Volumes113477
Prev Close335.5
Low332.35
Closing date2024-11-12
Historical performance
1 Year High395.95
3 Year High395.95
5 Year High449.00
1 Year Low112.35
3 Year Low107.00
5 Year Low85.95

Panacea Biotec Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
2087
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-1751.96
Dividend Yield
Dividend Yield
N/A

Panacea Biotec Investment Returns

1 Year
109.9%
3 Years
60.9%
5 Years
146.2%
10 Years
109.8%

Panacea Biotec Technicals

IndicatorsValueSignal
5-DMA361.91Bearish
10-DMA354.08Bearish
20-DMA334.84Bullish
50-DMA312.17Bullish
100-DMA234.47Bullish
200-DMA188.58Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors3997645507462364708548872
Government---------------

Panacea Biotec Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income258517110100
Operating Profit57-463-22866
Interest364418081853
Depreciation367391438456
Profit Before Tax1512814494-1442
Consolidated Net Profit-12-33210783-1477
Adjusted EPS----5176-24

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital61616161
Total Reserves835983758705-2348
Minority Interest-38-35-30-30
Total Non-Current Liabilities265127078519600
Total Liabilities14121144261735111774
Capital Work in Progress74728049212
Total Assets14121144261735111774

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-1-4225-10841068
Cash Flow from Investing Activities102430312826-477
Cash Flow from Financing Activitie-28-184-11758-471
Net Cash Inflow / Outflow73-105-17120
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -1751.96.
  • 3Y Stock Price CAGR of the stock is 19.1.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹57 Million.
  • The company generated revenue of ₹5592 Million in the previous financial year.

Panacea Biotec

335.5-14.3   (-4.1%)

Investment Amount: ₹ 15715
Current Value: ₹ 33550
Performence: 113.5%
P/L: ₹ 17835
Top Gainers
SymbolChange%
STCINDIA168.41(16%)
DEEDEV292.65(13%)
KIOCL402.15(12%)
NEULANDLAB15329.5(11%)
NSIL8169.9(11%)
Top Losers
SymbolChange%
BASF6702.75(-15%)
COASTCORP237.98(-14%)
SHIVATEX234.01(-13%)
JITFINFRA794(-13%)
GLOBUSSPR937.1(-12%)
MARSHALL24.8(-12%)
VISHNU434.25(-12%)
EMIL163.38(-11%)
Similar stocks

Innova Captab

33.5

954.05

October 12 - November 12

Vimta Labs

29.4

722

October 12 - November 12

Unichem Lab

23.4

877.05

October 12 - November 12

AMI Organics

23

2046.3

October 12 - November 12

Jagsonpal Pharma

19.6

561.45

October 12 - November 12

Wockhardt

18.5

1180.8

October 12 - November 12

Medico Remedies

17.2

56.24

October 12 - November 12

Piramal Pharma

13.2

250.6

October 12 - November 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month